These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 21550183)

  • 1. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry.
    Sanders JW; Tang C; Kudchadker RJ; Venkatesan AM; Mok H; Hanania AN; Thames HD; Bruno TL; Starks C; Santiago E; Cunningham M; Frank SJ
    Brachytherapy; 2023; 22(6):822-832. PubMed ID: 37716820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of intraoperative dosimetry for prostate brachytherapy using registered ultrasound and fluoroscopy.
    Lee J; Hobbs RF; Zahurak M; Ng SK; Zhang Z; Burdette EC; DeWeese TL; Song DY
    Brachytherapy; 2018; 17(6):858-865. PubMed ID: 30217432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment.
    Shaikh T; Zaorsky NG; Ruth K; Chen DY; Greenberg RE; Li J; Crawford K; Horwitz EM
    Brachytherapy; 2015; 14(3):316-21. PubMed ID: 25454576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a deep learning-based magnetic resonance imaging only workflow for postimplant dosimetry in I-125 seed brachytherapy for prostate cancer.
    Grigo J; Karius A; Hanspach J; Mücke L; Laun FB; Huang Y; Strnad V; Fietkau R; Bert C; Putz F
    Brachytherapy; 2024; 23(1):96-105. PubMed ID: 38008648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.
    Nath R; Bice WS; Butler WM; Chen Z; Meigooni AS; Narayana V; Rivard MJ; Yu Y;
    Med Phys; 2009 Nov; 36(11):5310-22. PubMed ID: 19994539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate size, source configuration, and dosimetry dynamics of stranded
    Sloboda RS; Liu D; Chng N; Wachowicz K; Usmani N
    Brachytherapy; 2024; 23(5):497-513. PubMed ID: 38853064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer.
    Henderson DR; Tree AC; Harrington KJ; van As NJ
    Medicines (Basel); 2018 Apr; 5(2):. PubMed ID: 29621134
    [No Abstract]   [Full Text] [Related]  

  • 8. CT-MR Image Fusion for Post-Implant Dosimetry Analysis in Brain Tumor Seed Implantation- a Preliminary Study.
    Zhang M; Chu C; Huang L; Hu B
    Dis Markers; 2022; 2022():6310262. PubMed ID: 35620270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between intraplan and postplan parameters in I-125 permanent prostate brachytherapy using loose seeds or linked seeds.
    Ito F; Kobayashi H; Ito M; Shiroki R; Hayashi S
    Nagoya J Med Sci; 2022 Feb; 84(1):111-119. PubMed ID: 35392000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of post-implant dosimetrics between intraoperatively built custom-linked seeds and loose seeds by sector analysis at 24 hours and 1 month for localized prostate cancer.
    Okazaki E; Kuratsukuri K; Nishikawa T; Tanaka T; Sakagami M; Shibuya K
    J Contemp Brachytherapy; 2020 Aug; 12(4):317-326. PubMed ID: 33293970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging.
    Delouya G; Carrier JF; Xavier-Larouche R; Hervieux Y; Béliveau-Nadeau D; Donath D; Taussky D
    Cureus; 2018 Mar; 10(3):e2394. PubMed ID: 29850389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?
    Taussky D; Igidbashian L; Donath D; Béliveau-Nadeauv D; Larouche RX; Hervieux Y; Delouya G
    J Contemp Brachytherapy; 2017 Aug; 9(4):304-308. PubMed ID: 28951748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience.
    Lim TY; Kudchadker RJ; Wang J; Bathala T; Szklaruk J; Pugh TJ; Mahmood U; Ibbott GS; Frank SJ
    J Contemp Brachytherapy; 2016 Jun; 8(3):235-42. PubMed ID: 27504133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a urinary catheter on seed position and rectal and bladder doses in CT-based post-implant dosimetry for prostate cancer brachytherapy.
    Kunogi H; Yamaguchi N; Wakumoto Y; Sasai K
    J Contemp Brachytherapy; 2015 Jun; 7(3):211-7. PubMed ID: 26207109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new two-step accurate CT-MRI fusion technique for post-implant prostate cancer.
    Kunogi H; Hojo H; Wakumoto Y; Saito AI; Ishikura S; Yamashiro Y; Kuwatsuru R; Sasai K
    J Contemp Brachytherapy; 2015 Apr; 7(2):117-21. PubMed ID: 26034491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved dosimetry in prostate brachytherapy using high resolution contrast enhanced magnetic resonance imaging: a feasibility study.
    Buch K; Morancy T; Kaplan I; Qureshi MM; Hirsch AE; Rofksy NM; Holupka E; Oismueller R; Hawliczek R; Helbich TH; Bloch BN
    J Contemp Brachytherapy; 2015 Jan; 6(4):337-43. PubMed ID: 25834576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of imaging in radiation therapy planning: past, present, and future.
    Pereira GC; Traughber M; Muzic RF
    Biomed Res Int; 2014; 2014():231090. PubMed ID: 24812609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisector dosimetry in the immediate post-implant period: significant under dosage of the prostate base.
    Kirschner AN; Sathiaseelan V; Zhang Y; David J; Kalapurakal JA
    J Contemp Brachytherapy; 2014 Mar; 6(1):33-9. PubMed ID: 24790620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of CT and MR-CT fusion for prostate post-implant dosimetry.
    Maletz KL; Ennis RD; Ostenson J; Pevsner A; Kagen A; Wernick I
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1912-7. PubMed ID: 21550183
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.